Reply by Authors

Hans Veerman^{1

2

3}, Aletta P I Houwink⁴, Peter F E Schutte⁴, Jakko A Nieuwenhuijzen^{2

3}, Ton A Roeleveld^{3

5}, Esther Wit^{1

3}, Jan Willem Mazel^{3

6}, Tim M van der Sluis^{2

3}, André N Vis^{2

3}, Pim J van Leeuwen^{1

3}, Henk G van der Poel^{1

3}

Affiliations

¹ Department of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
² Department of Urology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
³ Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.
⁴ Department of Anesthesiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
⁵ Department of Urology, Noord-West Ziekenhuis, Den Helder, the Netherlands.
⁶ Department of Urology, Spaarne Gasthuis, Hoofddorp, the Netherlands.

Comment

Hans Veerman et al. J Urol. 2021 Jun.

. 2021 Jun;205(6):1680.

doi: 10.1097/JU.0000000000001645.02. Epub 2021 Mar 18.

¹ Department of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
² Department of Urology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
³ Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.
⁴ Department of Anesthesiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
⁵ Department of Urology, Noord-West Ziekenhuis, Den Helder, the Netherlands.
⁶ Department of Urology, Spaarne Gasthuis, Hoofddorp, the Netherlands.

No abstract available

Comment on

Editorial Comment.
Breau RH, Lusty A. Breau RH, et al. J Urol. 2021 Jun;205(6):1679-1680. doi: 10.1097/JU.0000000000001645.01. Epub 2021 Mar 18. J Urol. 2021. PMID: 33734853 No abstract available.